Literature DB >> 23070023

Discriminative stimulus effects of N,N-diisopropyltryptamine.

Theresa M Carbonaro1, Michael J Forster, Michael B Gatch.   

Abstract

RATIONALE: Serotonergic hallucinogens such as (+)-lysergic acid diethylamide (LSD) and dimethyltryptamine (DMT) produce distinctive visual effects, whereas the synthetic hallucinogen N,N-diisopropyltryptamine (DiPT) is known for its production of auditory distortions.
OBJECTIVE: This study compares the discriminative stimulus effects of DiPT to those of visual hallucinogens.
METHODS: Adult male rats were trained to discriminate DiPT (5 mg/kg, 15 min) from saline under a FR10 schedule. A dose-effect and time course of DiPT's discriminative stimulus effects were established. DMT, (-)-2,5-dimethoxy-4-methylamphetamine (DOM), LSD, (±)-methylenedioxymethamphetamine (MDMA), and (+)-methamphetamine were tested for cross-substitution in DiPT-trained animals.
RESULTS: Rats learned to discriminate DiPT from saline in an average of 60 training sessions (30 drug and 30 saline). DiPT (0.5-5 mg/kg) produced dose-dependent increases in drug-appropriate responding (DAR) to 99 % (ED(50) = 2.47 mg/kg). Onset of the discriminative stimulus effects was within 5 min, and the effects dissipated within 4 h. Full substitution for the discriminative stimulus effects of DiPT occurred with LSD, DOM, and MDMA. DMT only partially substituted for DiPT (65 % DAR), whereas (+)-methamphetamine failed to substitute for DiPT (29 % DAR).
CONCLUSIONS: The discriminative stimulus effects of DiPT were similar those of a number of synthetic hallucinogens, only partially similar to those of DMT, but not similar to (+)-methamphetamine. The putative DiPT-induced auditory distortions do not lead to discriminative stimulus effects distinguishable from other hallucinogens.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23070023      PMCID: PMC3577941          DOI: 10.1007/s00213-012-2891-x

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  18 in total

1.  Abuse liability profile of three substituted tryptamines.

Authors:  Michael B Gatch; Michael J Forster; Aaron Janowsky; Amy J Eshleman
Journal:  J Pharmacol Exp Ther       Date:  2011-04-07       Impact factor: 4.030

2.  Hallucinogenic drug interactions with neurotransmitter receptor binding sites in human cortex.

Authors:  P A Pierce; S J Peroutka
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

3.  DOM-stimulus generalization to LSD and other hallucinogenic indolealkylamines.

Authors:  R A Glennon; R Young; J M Jacyno; M Slusher; J A Rosecrans
Journal:  Eur J Pharmacol       Date:  1983-01-21       Impact factor: 4.432

Review 4.  Hallucinogens.

Authors:  David E Nichols
Journal:  Pharmacol Ther       Date:  2004-02       Impact factor: 12.310

Review 5.  Site-selective serotonin agonists as discriminative stimuli.

Authors:  R A Glennon
Journal:  Psychopharmacol Ser       Date:  1988

6.  N, N-Diisopropyltryptamine (DIPT) and 5-methoxy-N,N-diisopropyltryptamine (5-MeO-DIPT). Two orally active tryptamine analogs with CNS activity.

Authors:  A T Shulgin; M F Carter
Journal:  Commun Psychopharmacol       Date:  1980

7.  LDS-25 as a discriminative stimulus for response selection by pigeons.

Authors:  T U Järbe
Journal:  Pharmacol Biochem Behav       Date:  1980-10       Impact factor: 3.533

8.  Differential tolerance to biological and subjective effects of four closely spaced doses of N,N-dimethyltryptamine in humans.

Authors:  R J Strassman; C R Qualls; L M Berg
Journal:  Biol Psychiatry       Date:  1996-05-01       Impact factor: 13.382

9.  Discriminative stimulus properties of phenylisopropylamine derivatives.

Authors:  R A Glennon
Journal:  Drug Alcohol Depend       Date:  1986-06       Impact factor: 4.492

10.  Radioligand binding evidence implicates the brain 5-HT2 receptor as a site of action for LSD and phenylisopropylamine hallucinogens.

Authors:  M Titeler; R A Lyon; R A Glennon
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

View more
  5 in total

1.  The role of 5-HT2A, 5-HT 2C and mGlu2 receptors in the behavioral effects of tryptamine hallucinogens N,N-dimethyltryptamine and N,N-diisopropyltryptamine in rats and mice.

Authors:  Theresa M Carbonaro; Amy J Eshleman; Michael J Forster; Kejun Cheng; Kenner C Rice; Michael B Gatch
Journal:  Psychopharmacology (Berl)       Date:  2014-07-03       Impact factor: 4.530

Review 2.  Neuropharmacology of N,N-dimethyltryptamine.

Authors:  Theresa M Carbonaro; Michael B Gatch
Journal:  Brain Res Bull       Date:  2016-04-25       Impact factor: 4.077

3.  The use patterns of novel psychedelics: experiential fingerprints of substituted phenethylamines, tryptamines and lysergamides.

Authors:  P Mallaroni; N L Mason; F R J Vinckenbosch; J G Ramaekers
Journal:  Psychopharmacology (Berl)       Date:  2022-04-30       Impact factor: 4.415

Review 4.  Recreational use, analysis and toxicity of tryptamines.

Authors:  Roberta Tittarelli; Giulio Mannocchi; Flaminia Pantano; Francesco Saverio Romolo
Journal:  Curr Neuropharmacol       Date:  2015-01       Impact factor: 7.363

5.  Trips and neurotransmitters: Discovering principled patterns across 6850 hallucinogenic experiences.

Authors:  Galen Ballentine; Samuel Freesun Friedman; Danilo Bzdok
Journal:  Sci Adv       Date:  2022-03-16       Impact factor: 14.136

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.